Does PEGCETACOPLAN Cause Haemoglobin decreased? 106 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 106 reports of Haemoglobin decreased have been filed in association with PEGCETACOPLAN (Empaveli). This represents 7.7% of all adverse event reports for PEGCETACOPLAN.
106
Reports of Haemoglobin decreased with PEGCETACOPLAN
7.7%
of all PEGCETACOPLAN reports
1
Deaths
51
Hospitalizations
How Dangerous Is Haemoglobin decreased From PEGCETACOPLAN?
Of the 106 reports, 1 (0.9%) resulted in death, 51 (48.1%) required hospitalization, and 2 (1.9%) were considered life-threatening.
Is Haemoglobin decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEGCETACOPLAN. However, 106 reports have been filed with the FAERS database.
What Other Side Effects Does PEGCETACOPLAN Cause?
Fatigue (135)
Visual impairment (125)
Haemolysis (100)
Off label use (97)
Vitreous floaters (78)
Breakthrough haemolysis (67)
Headache (66)
Product dose omission issue (59)
Uveitis (59)
Covid-19 (56)
What Other Drugs Cause Haemoglobin decreased?
LENALIDOMIDE (4,031)
RUXOLITINIB (3,297)
ECULIZUMAB (3,028)
ADALIMUMAB (2,459)
CLOZAPINE (2,396)
RITUXIMAB (1,803)
APIXABAN (1,779)
NIRAPARIB (1,759)
METHOTREXATE (1,754)
RIBAVIRIN (1,753)
Which PEGCETACOPLAN Alternatives Have Lower Haemoglobin decreased Risk?
PEGCETACOPLAN vs PEGFILGRASTIM
PEGCETACOPLAN vs PEGFILGRASTIM-APGF
PEGCETACOPLAN vs PEGFILGRASTIM-BMEZ
PEGCETACOPLAN vs PEGFILGRASTIM-CBQV
PEGCETACOPLAN vs PEGFILGRASTIM-JMDB